Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

“New Phase” Of Japanese Health Care Opens Door To U.S. Manufacturers

This article was originally published in The Gray Sheet

Executive Summary

A potential increase in the percentage of health care services paid for "out of pocket" by Japanese citizens will increase opportunities for the U.S. device industry to shape reforms of the country's health system, the Department of Commerce says

You may also be interested in...



U.S. Counters Japan’s Centers Of Excellence Criteria With New Reg Proposals

Initial criteria for inclusion of medical devices in Japan's recently established "centers of excellence" (CoE) program will focus on 50 high-end procedures identified by the country's Ministry of Health, Labor and Welfare

U.S. Counters Japan’s Centers Of Excellence Criteria With New Reg Proposals

Initial criteria for inclusion of medical devices in Japan's recently established "centers of excellence" (CoE) program will focus on 50 high-end procedures identified by the country's Ministry of Health, Labor and Welfare

U.S. Industry Preps Proposals To Unseat Japanese Foreign Reference Pricing

A group of U.S. medical device manufacturers is working to ensure that potential revisions to Japan's Pharmaceutical Affairs Law do not increase approval times for new products

Latest Headlines
See All
UsernamePublicRestriction

Register

MT016483

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel